Scientists test new Slow-Release pill for muscle disease
NCT ID NCT07154095
Summary
This study tested a new, long-acting version of a drug used for myasthenia gravis, a condition that causes muscle weakness. Researchers compared how the body absorbs and handles this new pill versus the standard pill. The study was done with 40 healthy volunteers to check for safety and how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Second University Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.